Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,335 | 5,629 | 1,564 | 720 | 1,307 |
| TOTAL | $9,569 | $5,978 | $1,785 | $840 | $1,424 |
| Non-Current Assets | |||||
| PPE Net | 399 | 426 | 427 | 330 | 344 |
| Other Non-Current Assets | 570 | 640 | 1,522 | 1,600 | 1,666 |
| TOTAL | $969 | $1,065 | $1,949 | $1,930 | $2,010 |
| Total Assets | $10,538 | $7,043 | $3,733 | $2,770 | $3,434 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,390 | 974 | 1,567 | 1,398 | 1,221 |
| Accrued Expenses | 1,169 | 288 | 457 | 363 | 333 |
| Other current liabilities | N/A | N/A | 281 | 200 | N/A |
| TOTAL | $3,186 | $1,915 | $2,953 | $2,253 | $1,876 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 33 | 33 | 33 | 33 |
| Other Non-Current Liabilities | 254 | 332 | 411 | 532 | 568 |
| TOTAL | $254 | $332 | $411 | $532 | $568 |
| Total Liabilities | $3,440 | $2,248 | $3,364 | $2,784 | $2,444 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 242 | 57 | 44 | 27 | 22 |
| Retained earnings | -65,323 | -60,949 | -58,975 | -57,348 | -56,188 |
| TOTAL | $7,098 | $4,795 | $369 | $-15 | $990 |
| Total Liabilities And Equity | $10,538 | $7,043 | $3,733 | $2,770 | $3,434 |